Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cherifa Taleb is active.

Publication


Featured researches published by Cherifa Taleb.


Soins. Gérontologie | 2017

Inhibiteurs de “check point”, quelles perspectives pour les patients âgés ?

Thierry Landre; Fatima Karaoud; Cherifa Taleb

The arrival of new immunotherapies, called checkpoint inhibitors, is radically changing the world of oncology. Currently, there are some twenty different cancers which may respond to this type of therapy. It is therefore important that professionals involved in the care of elderly people with cancer are already made aware of these new treatments. This article explains how these checkpoint inhibitors work and describes their efficacy and their toxicity for elderly patients.


European Journal of Internal Medicine | 2003

Hypovitaminosis C in hospitalized patients

Olivier Fain; J. Pariès; Benoı̂t Jacquart; Giséle Le Moël; A. Kettaneh; Jérôme Stirnemann; Célia Héron; Muriel Sitbon; Cherifa Taleb; E. Letellier; Bouchra Bétari; Liliane Gattegno; M. Thomas


Journal of Clinical Oncology | 2016

Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour?

Thierry Landre; Cherifa Taleb; Patrick Nicolas; Gaëtan Des Guetz


International Journal of Colorectal Disease | 2015

Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis

Thierry Landre; Bernard Uzzan; Patrick Nicolas; Thomas Aparicio; Laurent Zelek; Florence Mary; Cherifa Taleb; Gaetan Des Guetz


Archive | 2001

UN LOGICIEL INFORMATIQUE POUR LE SUIVI DES PATIENTS SOUS TRAITEMENT ANTI-TUBERCULEUX

Géraldine Bayol-Honnet; Olivier Fain; Véronique Joly; Gilbert Rocher; Fadi Antoun; Christine Debourdeau-Zammit; Zora Marjanovic; Cherifa Taleb; C. Toledano; Denis Coulombier; Claire Georges; Daniel Sereni; Philippe H. Lagrange; Jean-Louis Herrmann


Journal of Clinical Oncology | 2018

Efficacy of abemaciclib, palbociclib and ribociclib among the older compared with younger women in HR-positive/HER2-negative, advanced breast cancer.

Thierry Landre; Anna Fain; Emmanuelle Langeron; Lakhdar Mokrane; Cherifa Taleb


International Journal of Colorectal Disease | 2018

Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients

Thierry Landre; Emilie Maillard; Cherifa Taleb; Djamel Ghebriou; Gaetan Des Guetz; L. Zelek; Thomas Aparicio


Journal of Clinical Oncology | 2017

Impact of the addition of bevacizumab, oxaliplatin or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.

Thierry Landre; Thomas Aparicio; Djamel Ghebriou; Patrick Nicolas; Cherifa Taleb; Kader Chouahnia; Laurent Zelek; Gaëtan Des Guetz


Archive | 2014

Supportive care in elderly cancer patients P108 PAIN REPORTS AND PAIN MEDICATION TREATMENT IN ELDERLY PATIENTS WITH CANCER: A RETROSPECTIVE COHORT STUDY OF 311 PATIENTS

Thierry Landre; C. Peloso; Cherifa Taleb; F. Pamoukdjian; R. Ratiney; Georges Sebbane; G. Des Guetz; D. Tremblay; D. Roberge; D. Berbiche; B.-L. Nguyen


Journal of Geriatric Oncology | 2014

PAIN REPORTS AND PAIN MEDICATION TREATMENT IN ELDERLY PATIENTS WITH CANCER: A RETROSPECTIVE COHORT STUDY OF 311 PATIENTS

Thierry Landre; C. Peloso; Cherifa Taleb; F. Pamoukdjian; R. Ratiney; Georges Sebbane; G. Des Guetz

Collaboration


Dive into the Cherifa Taleb's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge